Furthermore, insulin has been evidenced as being a suppressor of UCP1 expression and mitochondrial respiration in WAT and BAT in vivo (Dallon et al., 2018), which may contribute to weight gain in patients with T2DM receiving insulin therapy (Dallon et al., 2018). This evidence concerns the gene UCP1 and type 2 diabetes mellitus.